Head-to-head
Amble vs Oak
Amble and Oak both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
Amble
Ranked #24 · Grade C
Best for: Working moms who want semaglutide specifically, on a no-video intake, and who will pay month to month rather than prepay — the prepaid tiers are non-refundable and there is no pause.
Visit AmbleOak
Higher scoreRanked #7 · Grade B
Best for: Working moms who want a fast, no-video start with bundled coaching at a flat price, and who will read the non-refundable, arbitration-bound terms and confirm their state before committing.
Visit OakThe verdict
Oak edges out Amble on the Rx-Readiness Score, 83 to 62 (B vs C). Working moms who want a fast, no-video start with bundled coaching at a flat price, and who will read the non-refundable, arbitration-bound terms and confirm their state before committing.
Amble is still a genuine option — a genuinely async start in 45 states, wrapped around a price page that advertises one molecule and hides the other: tirzepatide runs $329 a month, 84% over the headline, and you cannot find that out without starting the intake. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Amble | Oak |
|---|---|---|
| Rx-Readiness Score | 62/100 · C | 83/100 · B |
| Overall rank | #24 | #7 |
| Semaglutide | $179/mo | $119/mo |
| Tirzepatide | $329/mo (not published) | $185/mo |
| Coverage | All 50 claimed — exclusions never listed | Most states (not CA for compounded) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Amble
Ranked #24 · Grade C
What we like
- A real async start: in 45 states the online health review is the whole encounter, and Amble names the five states that need a short video or audio visit
- The semaglutide price ladder is public with no quiz-gate — $179 a month, down to $135 on six months
- Supplies, shipping and ongoing clinical monitoring are stated as included, with no separate membership fee, and HSA/FSA cards are accepted on three-month plans or longer
The caveats
- Only semaglutide is priced in public. Tirzepatide starts at $329 a month — 84% above the advertised $179 — and that ladder appears nowhere a shopper can read it before starting intake
- A $100 non-refundable 'visit and clinical fee' is written into the intake consent, contradicted by a 'no cancellation fee' screen two steps earlier, and absent from the Terms of Service entirely
- Prepaid plans are non-refundable, cancellation needs 15 days' notice, and the Terms warn that anyone disputing a charge to escape a commitment will be 'sent to collections and/or have further legal action pursued'
Oak
Ranked #7 · Grade B
What we like
- Async-first — 'no video calls required' — with same-day board-certified provider review
- Flat 'one price, all dosages' on both compounded semaglutide and tirzepatide, with free shipping
- Free health coaching bundled in — uncommon at this price point
The caveats
- 'No subscriptions' marketing conflicts with its Terms, which describe an auto-renewing subscription
- Orders are non-refundable once prescribed, with a binding-arbitration and class-action waiver
- Compounded isn't available in California; the exact per-tier price and named pharmacies aren't public
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Amble and Oak against other providers on our shortlist.
Or browse the full comparison hub.